Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

AIM: To investigate the feasibility of preoperative docetaxel, cisplatin and capecitabine (DCC) in patients with resectable gastric cancer. METHODS: Patients with resectable gastric cancer fulfilling the inclusion criteria, were treated with 4 cycles of docetaxel (60 mg/m(2)), cisplatin (60 mg/m(2))...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Gastrointest Surg
Autori principali: Dassen, Anneriet E, Bernards, Nienke, Lemmens, Valery E P P, van de Wouw, Yes A J, Bosscha, Koop, Creemers, Geert-Jan, Pruijt, Hans J F M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Inc 2016
Soggetti:
Clinical Trials Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5081553/
https://ncbi.nlm.nih.gov/pubmed/27830043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i10.706
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi